Share |

FDR AMULET Innovality: Innovation and Quality in Mammography

Volumetric solutions including 3D Mammography, Tomosynthesis and Biopsy in one system

04.03.2013

AMULET Innovality

AMULET Innovality

AMULET Innovality

AMULET Innovality

At the European Congress of Radiology (ECR) 2013 which is held from 7 to 11 March in Vienna, Austria, FUJIFILM Europe will present an addition to its lineup of AMULET systems. The new FDR AMULET Innovality will support all known volumetric methods within one device with a superior image level, reduced dose and improved patient comfort.

The FDR AMULET Innovality integrates a range of 3D applications in mammography examinations. Different tomosynthesis modes with variable dose and angulation are possible, allowing the user to be more flexible according to the clinical scenario. Advanced 3D visualization is also available using two high-resolution images taken from different angles as a dose efficient improvement of routine diagnosis.

The system is equipped with a new amorphous selenium (a-Se) detector, utilizing an advanced detector geometry with Hexagon Close Pattern (HCP) technology. This detector design leads to higher image sharpness and dose efficiency.
The detector structure provides approximately 20% dose reduction compared with the previous one, which was already one of the most efficient systems on the market. At the same time, the level of image detail makes the system a particularly attractive proposition.

In addition to the high technological standard, the new system was optimized for improved user ergonomics and better patient comfort. A remarkable reduction in pain during mammography examinations is now possible using new breast adaptive compression paddles.

The innovative intelligent automatic exposure control can be used even in the presence of implants, leading to improved workflow and the higher diagnostic value of routine mammography.

Using 3D Mammography for routine examinations can remarkably reduce the incidence of false positive diagnosis without a significant increase in dose compared to 2D Mammography. This in turn is likely to lead to a significant reduction in the number of biopsies and a related reduction of unnecessary stress for doctors and patients alike.

Further classification and evaluation of findings can be performed with using either one of two modes of Tomosynthesis for maximum dose reduction and excellent diagnostic quality.This allows for maximum confidence in reporting.

At ECR 2013 AMULET Innovality will be presented as a work in progress product.


The Fujifilm booth is located at the Austria Center Vienna, Expo B, Booth Nr. 210.

Files:

  • Medical Systems